Our GLP-3 (RUO) is a high-purity, lyophilized peptide engineered to target three distinct metabolic pathways. Unlike standard agonists, this “triple threat” sequence activates GLP-1, GIP, and Glucagon receptors simultaneously, offering researchers a comprehensive tool for studying advanced glucose regulation and caloric expenditure.
In stock
This compound has not been reviewed or approved by the FDA, EMA, MHRA, or any other global regulatory authority. No claims are made regarding safety, therapeutic potential, or disease-related effects. All information relates exclusively to controlled laboratory research, not clinical application.
By purchasing this product, the buyer confirms that:
They are a qualified researcher or institution
They will follow all lawful handling and storage requirements
All sales are final and provided without clinical warranty
This compound is intended exclusively for scientific experimentation and research-driven data development.
Every vial is linked to its own certificate of analysis — download the exact document for this batch before you order.
This batch's certificate of analysis is shown below. Click to view it full size.
Orders placed before 2 PM EST ship the same business days. Most US orders arrive within 1–3 business days with tracking. All shipments include temperature indicators to confirm cold-chain integrity on arrival.
SS-31-10MG (RUO)
TB-500-10MG (RUO)
CJC-1295 (No-DAC) + Ipamorelin 5MG + 5MG (RUO)
Research Storage Case
